First patient treated with CSA Medical ’ s AV spray catheter

CSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease.
The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the company said. It was recently cleared for use with CSA Medical’s truFreeze system – a cryosurgical tool used to ablate benign and malignant lesions.
Get the full story at our sister site, Drug Delivery Business News.
The post First patient treated with CSA Medical’s AV spray catheter appeared first on MassDevice.

Source: Mass Device - October 3, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Surgical CSA Medical Inc. Source Type: news